Skip to content

Poly Medicure targets 20% FY27 growth as it expands high-tech device portfolio

Poly Medicure expects its Europe business to recover and international revenue to grow 15% in FY27 as the medtech company accelerates development of advanced cardiology and orthopaedic devices to reduce import dependence and expand globally.​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *